Reactivity and sensitivity of commercially available influenza rapid diagnostic tests in Japan
Open Access
- 3 November 2017
- journal article
- research article
- Published by Springer Science and Business Media LLC in Scientific Reports
- Vol. 7 (1), 1-6
- https://doi.org/10.1038/s41598-017-14536-0
Abstract
Seasonal influenza virus routinely causes epidemic infections throughout the world. Sporadic infections by H5N1, H5N6, and H7N9 viruses are also reported. To treat patients suffering from such viral infections, broadly reactive and highly sensitive influenza rapid diagnostic tests (IRDTs) are required. Here, we examined the reactivity and sensitivity of 25 IRDTs available in Japan for the detection of seasonal H1N1pdm09, H3N2, and type B viruses, as well as highly pathogenic H5 and H7 viruses. All of the IRDTs tested detected the seasonal viruses and H5 and H7 viruses albeit with different sensitivities. Several IRDTs detected the H5 and H7 viruses and the seasonal viruses with similar (high) sensitivity.This publication has 22 references indexed in Scilit:
- Detection sensitivity of influenza rapid diagnostic testsMicrobiology and Immunology, 2014
- Influenza A(H5N2) Virus Antibodies in Humans after Contact with Infected Poultry, Taiwan, 2012Emerging Infectious Diseases, 2014
- Human Infection with a Novel Avian-Origin Influenza A (H7N9) VirusThe New England Journal of Medicine, 2013
- Viral load and rapid diagnostic test in patients with pandemic H1N1 2009Pediatrics International, 2011
- Laninamivir and its Prodrug, CS-8958: Long-Acting Neuraminidase Inhibitors for the Treatment of InfluenzaAntiviral Chemistry and Chemotherapy, 2010
- Sensitivity of Influenza Rapid Diagnostic Tests to H5N1 and 2009 Pandemic H1N1 VirusesJournal of Clinical Microbiology, 2010
- Sensitivity of rapid immunoassay for influenza A and B in the early phase of the diseasePediatrics International, 2009
- Human H5N2 Avian Influenza Infection in Japan and the Factors Associated with High H5N2-Neutralizing Antibody TiterJournal of Epidemiology, 2008
- Nonpharmaceutical Interventions for Pandemic Influenza, International MeasuresEmerging Infectious Diseases, 2006
- Neuraminidase Inhibitors: Zanamivir and OseltamivirAnnals of Pharmacotherapy, 2001